PAYSPAYSTechnology · Software - Infrastructure

PAYS Stock Forecast: PaySign, Inc. Price Predictions for 2026-2027

Last close, 14 Sept 2026
$13
−1.38% on the day

The 5 Wall Street analysts covering PaySign, Inc. hold a median 12-month price target of $13 — +1.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 85 of 100 as at 14 Sept 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$724.4M
Ticker Nerd rank
85 / 100
Median analyst target
$13
Analysts covering
5
Revenue$28.3M+48.1% y/y
Operating income$7.0M
Net income$6.8M
Free cash flow−$147K
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−4.6%
1M
−2.6%
YTD
+149.1%
1Y
+132.0%
From 52W high
−9.3%
From 52W low
+303.5%
$3
$14
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

PAYS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores PaySign, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Sept 2026
85 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
98
Revisions
97
Quality
92
Growth
91
Volatility
67
Size
49
Issuance
35
Value
31
Accruals
11

Momentum (98): The shares have been drifting up relative to others.

Accruals (11): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

PAYS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on PAYS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$2$4$6$8$10$12$14$16Oct 25Jan 26Apr 26Jul 26PAYSHigh $15Median $13Low $12

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says5 analysts
5 Buy0 Hold0 Sell
Low $12Median $13High $15

The green dot is the last close — the median target sits +1.3% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
6 Aug 2026DA DavidsonMaintainsBuy$9.00$12
13 May 2026DA DavidsonMaintainsBuy
13 May 2026DA DavidsonMaintainsBuy$9.00
26 Mar 2026DA DavidsonMaintainsBuy
25 Mar 2026Lake StreetMaintainsBuy
13 Nov 2025DA DavidsonMaintainsBuy
7 Aug 2025DA DavidsonMaintainsBuy
6 Aug 2025Lake StreetMaintainsBuy
26 June 2025Lake StreetMaintainsBuy
13 June 2025DA DavidsonMaintainsBuy
14 May 2025DA DavidsonMaintainsBuy
9 May 2025Ladenburg ThalmannMaintainsBuy
9 May 2025Lake StreetMaintainsBuy
27 Mar 2025Barrington ResearchMaintainsOutperform
26 Mar 2025Barrington ResearchMaintainsOutperform
26 Mar 2025DA DavidsonMaintainsBuy
20 Dec 2024Lake StreetInitiatesBuy
6 Nov 2024Barrington ResearchMaintainsOutperform
4 Nov 2024Barrington ResearchMaintainsOutperform
28 June 2024Barrington ResearchMaintainsOutperform

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. PAYS appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

PAYS vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Sept 2026, PaySign, Inc. returned +132.0% against +17.0% for the S&P 500, dividends included.

PAYS vs S&P 500, last 12 monthsTotal return, rebased to 100
50100150200250Oct 25Jan 26Apr 26Jul 26PAYSS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

PAYS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+60.7%
Analysts raising
2
Analysts cutting
0
Fundamentals

PaySign, Inc. (PAYS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
49.3×

Cheaper than 14% of US stocks

Price / sales
7.2×

Cheaper than 18% of US stocks

Price / book
12.0×

Cheaper than 8% of US stocks

EV / EBITDA
25.9×

Cheaper than 10% of US stocks

Growth & margins
Revenue growth (YoY)
48.1%

Higher than 85% of US stocks

Earnings growth (YoY)
386.9%

Higher than 94% of US stocks

Gross margin
63.3%

Higher than 76% of US stocks

Operating margin
28.3%

Higher than 86% of US stocks

Net margin
15.7%

Higher than 78% of US stocks

Returns & dividend
Return on equity
30.8%

Higher than 88% of US stocks

Return on assets
4.3%

Higher than 73% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

PaySign, Inc. (PAYS) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • PaySign, Inc. has a market value of $724.4M and an enterprise value of $702.7M.

  • Revenue in the twelve months to 30 June 2026: $100.6M. The latest quarter grew 48.1% year on year.

  • Net income over the same four quarters: $15.8M, a 15.7% net margin.

  • Diluted earnings per share, trailing twelve months: $0.26.

  • Free cash flow in the twelve months to 30 June 2026: $67.6M, after $5.5M of capital spending.

  • PaySign, Inc. spent $0.0 on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 56.4M.

  • Trailing P/E: 49.3×; forward P/E: 21.2× — the forward figure prices analyst consensus estimates, not reported earnings.

  • PaySign, Inc. employs 226 people $445K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 15 Sept 2026

Data provided by Twelve Data

Peers

PAYS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSoftware - Infrastructure
CompanyMarket capTKN rank
PAYSPaySign, Inc.$724.4M
85
CCSIConsensus Cloud Solutions, Inc.$700.6M
96
KDKKodiak AI, Inc.$745.8M
8
OSPNOneSpan, Inc.$656.4M
80
YEXTYext, Inc.$648.7M
92
BLZEBackblaze, Inc.$794.8M
80
KPLTKatapult Holdings, Inc.$808.5M
54

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own PaySign, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest PAYS news & analysis

Top Stocks Averaging 100% Forward EPS Growth To Combat AI Capex Fatigue

Seeking Alpha · 2 Sept 2026neutral

Seeking Alpha highlights stocks with strong forward earnings-per-share growth as a way for investors to diversify beyond AI infrastructure spending amid AI capex fatigue. It suggests consumer finance, healthcare payments, and health insurance as sectors that may support continued earnings expansion independent of AI investment.

Why it matters — PaySign, a healthcare payments company, may benefit from investor attention shifting toward growth stocks in consumer finance and healthcare payments that are not dependent on AI infrastructure spending.

Paysign Targets $117M Revenue as Patient-Affordability Business Surges

MarketBeat · 28 Aug 2026positive

Paysign is targeting $117 million in revenue as its patient-affordability business surges. CFO Jeff Baker described the company's two healthcare-focused businesses: plasma-donor payment services and pharmaceutical patient-affordability programs.

Why it matters — A PAYS watcher would care because the company has publicly set a specific revenue target amid reported strength in its patient-affordability segment, which underpins its healthcare-focused growth narrative.

Paysign (PAYS) is an Incredible Growth Stock: 3 Reasons Why

Zacks Investment Research · 26 Aug 2026positive

A Zacks Investment Research article highlights Paysign (PAYS) as a growth stock, citing its above-average growth in financials and positioning to outperform the broader market.

Why it matters — For PAYS watchers, the article points to the company's above-average financial growth as a notable positive signal for its market performance.

Paysign (PAYS) Upgraded to Buy: What Does It Mean for the Stock?

Zacks Investment Research · 26 Aug 2026positive

Paysign (PAYS) was upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. The upgrade signals potentially stronger near-term performance for the stock.

Why it matters — A Zacks Rank upgrade to Buy reflects improved earnings expectations, which PAYS watchers would track as a shift in analyst sentiment toward the company.

Paysign, Inc. to Present at the 17th Annual Midwest IDEAS Investor Conference

Business Wire · 18 Aug 2026neutral

Paysign, Inc. announced it will present at the 17th Annual Midwest IDEAS Investor Conference, scheduled for August 26-27, 2026, in Chicago, Illinois. The invitation-only conference features quality public companies.

Why it matters — Paysign's participation in an investor conference provides an opportunity for the company to present to institutional investors, raising its visibility in the investment community.

FAQ

Frequently asked questions about PAYS stock

What is the PAYS stock price forecast for 2026-2027?

The 5 Wall Street analysts covering PaySign, Inc. have a median 12-month price target of $13, with estimates ranging from $12 to $15. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is PAYS stock a buy right now?

Of the 5 analysts covering PaySign, Inc., 5 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks PaySign, Inc. 85 out of 100 across roughly 4,600 US stocks as at 14 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank PAYS?

As at 14 Sept 2026, PaySign, Inc. ranks 85 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (98 of 100).

Will PAYS stock go up?

No one can know that. What the data says: the median 12-month target from 5 analysts implies +1.3% from the last close, and Ticker Nerd's factor model ranks PaySign, Inc. 85 out of 100 as at 14 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the PAYS stock forecast for 2030?

No analyst covering PaySign, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for PAYS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $12 to $15 over the next 12 months.

How has PAYS stock performed over the past year?

PaySign, Inc. returned +132.0% over the 12 months to 14 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does PaySign, Inc. do?

Paysign Inc. is a financial technology and payment solutions company that specializes in prepaid card programs, integrated payment processing, and digital banking services.

What is the latest news on PAYS?

The most recent item we track (Seeking Alpha, 2 Sept 2026): "Top Stocks Averaging 100% Forward EPS Growth To Combat AI Capex Fatigue". Seeking Alpha highlights stocks with strong forward earnings-per-share growth as a way for investors to diversify beyond AI infrastructure spending amid AI capex fatigue. It suggests consumer finance, healthcare payments, and health insurance as sectors that may support continued earnings expansion independent of AI investment.

Company

About PaySign, Inc.

Paysign Inc. is a financial technology and payment solutions company that specializes in prepaid card programs, integrated payment processing, and digital banking services. Paysign designs customized card-based solutions for businesses, healthcare organizations, pharmaceutical companies, and government institutions, supporting use cases such as rewards, incentives, reimbursements, donor compensation, and patient affordability programs. The company also provides cardholder servicing, customer support, reporting tools, and communications features that help clients manage specialized payment workflows with greater efficiency and compliance. Its product suite includes virtual, physical, and reloadable payment options, along with software-enabled tools for administration and program oversight. Paysign Inc. serves clients across industries including healthcare, life sciences, retail, hospitality, and other commercial sectors, positioning itself as a provider of tailored payment infrastructure for organizations that need flexible, secure, and customizable disbursement solutions.

CEO Mr. Mark R. Newcomer · 226 employees · United States · https://www.paysign.com